$Atea Pharmaceuticals, Inc.(AVIR)$
AT-527
Phase 1 - March 21 (Successful)
Phase 2 - Oct 21 (Failure)
Phase 3 - Jun 22 ( Likely to be successful from the medical test history experience)
Thus to conclude, this is a good BUY for mid-long term.
$Atea Pharmaceuticals, Inc.(AVIR)$
AT-527
Phase 1 - March 21 (Successful)
Phase 2 - Oct 21 (Failure)
Phase 3 - Jun 22 ( Likely to be successful from the medical test history experience)
Thus to conclude, this is a good BUY for mid-long term.
精彩评论